David L. Pompliano
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David L. Pompliano.
Chemistry & Biology | 1998
Jeffrey H. Toney; Paula M. D. Fitzgerald; Nandini Grover-Sharma; Steven H. Olson; Walter J. May; Jon G. Sundelof; Dana E. Vanderwall; Kelly A. Cleary; Stephan K. Grant; Joseph K. Wu; John W. Kozarich; David L. Pompliano; Gail G. Hammond
BACKGROUNDnHigh level resistance to carbapenem antibiotics in gram negative bacteria such as Bacteroides fragilis is caused, in part, by expression of a wide-spectrum metallo-beta-lactamase that hydrolyzes the drug to an inactive form. Co-administration of metallo-beta-lactamase inhibitors to resistant bacteria is expected to restore the antibacterial activity of carbapenems.nnnRESULTSnBiphenyl tetrazoles (BPTs) are a structural class of potent competitive inhibitors of metallo-beta-lactamase identified through screening and predicted using molecular modeling of the enzyme structure. The X-ray crystal structure of the enzyme bound to the BPT L-159,061 shows that the tetrazole moiety of the inhibitor interacts directly with one of the two zinc atoms in the active site, replacing a metal-bound water molecule. Inhibition of metallo-beta-lactamase by BPTs in vitro correlates well with antibiotic sensitization of resistant B. fragilis.nnnCONCLUSIONSnBPT inhibitors can sensitize a resistant B. fragilis clinical isolate expressing metallo-beta-lactamase to the antibiotics imipenem or penicillin G but not to rifampicin.
Bioorganic & Medicinal Chemistry Letters | 1999
Mark L. Greenlee; Joanne B. Laub; James M. Balkovec; Milton L. Hammond; Gail G. Hammond; David L. Pompliano; Jeffrey H. Epstein-Toney
Potent thioester and thiol inhibitors of IMP-1 metallo-β-lactamase have been synthesized employing a solid-phase Mitsunobu reaction as the key step.
Gene | 1998
Mohamed El-Sherbeini; Wayne M. Geissler; Jamya Pittman; Xiling Yuan; Kenny K. Wong; David L. Pompliano
Bacterial UDP-N-acetylmuramyl-L-alanine:D-glutamate ligase (MurD), a cytoplasmic peptidoglycan biosynthetic enzyme, catalyzes the ATP-dependent addition of D-glutamate to an alanyl residue of the UDP-N-acetylmuramyl-L-alanine precursor, generating the dipeptide. The murD gene was cloned from both Staphylococcus aureus and Streptococcus pyogenes. Sequence analysis of the S. aureus murD gene revealed an open reading frame of 449 amino acids. The deduced aa sequence of S. aureus MurD is highly homologous to MurD from Escherichia coli, Haemophilus influenzae, Bacillus subtilis and St. pyogenes. Recombinant MurD protein from both S. aureus and St. pyogenes was separately overproduced in E. coli and purified as His-tagged fusion. Both recombinant enzymes catalyzed the ATP-dependent addition of D-glutamate to the precursor sugar peptide.
Fems Microbiology Letters | 1999
Gail G. Hammond; Joann Huber; Mark L. Greenlee; Joanne B. Laub; Katherine Young; Lynn L. Silver; James M. Balkovec; KellyAnn D. Pryor; Joseph K. Wu; Barbara Leiting; David L. Pompliano; Jeffrey H. Toney
Journal of Organic Chemistry | 1998
Binqi Zeng; Kenny K. Wong; David L. Pompliano; Sreelatha Reddy; Martin E. Tanner
Archive | 1992
B Jackson Gibbs.; Elaine Rands; David L. Pompliano; Victor M. Garsky
Protein Expression and Purification | 1997
Jeffrey H. Toney; Joseph K. Wu; Karen M. Overbye; Chris M. Thompson; David L. Pompliano
Archive | 1992
Jackson B. Gibbs; Elaine Rands; David L. Pompliano; Victor M. Garsky
Archive | 1994
Neville J. Anthony; David L. Pompliano
Archive | 1997
Renee M. Chabin; David W. Kuo; John F. O'Connell; David L. Pompliano; Kenny K. Wong